View Section: Price ratios
Biogen Pharmachem Statements
53
Biogen Pharmachem Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2023-03-31
%
—
100
—
0
—
0
—
0
1.596
0
2.105
0
-2.105
0
—
0
3.15
0
1.045
0
—
0
1.045
0
0.002
652.45
2022-09-30
%
-15.368
100
—
0
-15.368
0
—
0
0.149
0
1.623
0
-16.991
0
—
0
20.501
0
3.51
0
—
0
3.51
0
0.006
649.85
2022-03-31
%
0
100
0.001
-4566.7
-0.001
4666.7
—
0
0.264
-440000
3.911
-12441200
-3.913
12445866.7
—
0
1.711
-4746066.7
-2.202
7699800
—
0
-2.202
7699800
-0.003
652.6
2021-09-30
%
24.742
100
20.149
84.4
4.593
15.6
—
0
0.278
1.1
0.833
1.2
3.76
14.3
—
0
-1.644
-13.4
2.116
0.9
—
0
2.116
0.9
0.003
652.6
View Section: Balance Sheet